14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NEU.AX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Neuren Pharmaceuticals Limited stock downgraded from Buy Candidate to Hold/Accumulate after Friday trading session.
(Updated on May 17, 2024)

Buy or Hold candidate since May 15, 2024 Loss -1.17% PDF

The Neuren Pharmaceuticals Limited stock price fell by -3.26% on the last day (Friday, 17th May 2024) from $21.80 to $21.09. During the last trading day the stock fluctuated 3.57% from a day low at $21.03 to a day high of $21.78. The price has been going up and down for this period, and there has been a 7.06% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -453 thousand shares and in total, 340 thousand shares were bought and sold for approximately $7.17 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.71% during the next 3 months and, with a 90% probability hold a price between $18.00 and $21.20 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NEU.AX Signals & Forecast

The Neuren Pharmaceuticals Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $20.27 and $20.05. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 16, 2024, and so far it has fallen -3.26%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Neuren Pharmaceuticals Limited stock

Neuren Pharmaceuticals Limited finds support from accumulated volume at $20.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.750 between high and low, or 3.57%. For the last week, the stock has had daily average volatility of 5.00%.

Our recommended stop-loss: $20.05 (-4.94%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (NEU.AX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Neuren Pharmaceuticals Limited to open at $21.30, and during the day (based on 14 day Average True Range), to move between $20.20 and $21.98, which gives a possible trading interval of +/-$0.89 (+/-4.21%) up or down from last closing price. If Neuren Pharmaceuticals Limited takes out the full calculated possible swing range there will be an estimated 8.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $21.13 (0.19%) than the support at $20.74 (1.66%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Neuren Pharmaceuticals Limited stock A Buy?

Neuren Pharmaceuticals Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.547 Hold/Accumulate Downgraded

Predicted Opening Price for Neuren Pharmaceuticals Limited of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$21.30 ( 1.00%) $21.09

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NEU.AX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 22.05 4.55 %
R2 21.76 3.19 %
R1 21.59 2.35 %
Current price: 21.09
Support S1 21.01 -0.363 %
S2 20.84 -1.20 %
S3 20.55 -2.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 21.84 3.56 %
R2 21.80 3.37 %
R1 21.13 0.190 %
Current price 21.09
Support S1 20.74 -1.66%
S2 19.31 -8.44%
S3 19.15 -9.20%

FAQ

What is the symbol for Neuren Pharmaceuticals Limited Stock and on which exchange is it traded?
The symbol for Neuren Pharmaceuticals Limited is NEU.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Neuren Pharmaceuticals Limited Stock?
Neuren Pharmaceuticals Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Neuren Pharmaceuticals Limited Stock?
Neuren Pharmaceuticals Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Neuren Pharmaceuticals Limited Stock.

What's the current price of Neuren Pharmaceuticals Limited Stock?
As of the end of day on the May 17, 2024, the price of an Neuren Pharmaceuticals Limited (NEU.AX) share was $21.09.

What is the 52-week high and low for Neuren Pharmaceuticals Limited Stock?
The 52-week high for Neuren Pharmaceuticals Limited Stock is $25.95 and the 52-week low is $10.02.

What is the market capitalization of Neuren Pharmaceuticals Limited Stock?
As of the May 17, 2024, the market capitalization of Neuren Pharmaceuticals Limited is 2.69B.

When is the next earnings date for Neuren Pharmaceuticals Limited?
The upcoming earnings date for Neuren Pharmaceuticals Limited is Jul 29, 2024.
Click to get the best stock tips daily for free!

About Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as has completed Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase I clinical trial for the treatment of Phelan-McDermid, Angelman, Pitt Hopkins, and ... NEU.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT